Prokarium
- Industrial
- London, United Kingdom
Overview
Prokarium is a biopharmaceutical company at the forefront of applying synthetic biology to create novel cancer treatments.
Our lead program, currently advancing in clinical trials for bladder cancer, is redesigning the treatment paradigm for patients. Prokarium's Living Cures platform aims to transform precision medicine with off-the-shelf programmable therapeutics, promising a new class of immunotherapies that are sustainable, accessible and highly effective.
Please note that we have received the FDA’s IND approval for our lead program in bladder cancer, which you can read about here
Company details
- Sector: Medical technology
- Product: Vaxonella Oral Vaccine